A synthetic intelligence-powered technique for detecting tumor DNA in blood has proven unprecedented sensitivity in predicting most cancers recurrence. The brand new know-how has the potential to enhance most cancers care with the very early detection of recurrence and shut monitoring of tumor response throughout remedy.